A Trial of Rigid Versus Semirigid Thoracoscopy in the Evaluation of Exudative Pleural Effusions
- Conditions
- Pleurisy With Effusion
- Interventions
- Device: Rigid thoracoscope (Richard Wolf GmbH, Knittlingen, Germany)Device: Semirigid thoracoscope (model LTF-160Y1, Olympus, Japan)
- Registration Number
- NCT01726556
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
- Brief Summary
Rigid thoracoscopy is an established procedure for the performance of pleural biopsies for undiagnosed pleural effusions. The semirigid thoracoscope is a relatively new instrument designed for the same purpose which is claimed to be more user-friendly. The two devices have not been compared in a head-to-head trial in published literature. The investigators attempt to conduct a randomised comparative trial between the two devices.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- Patients with an exudative (as defined by Light's criteria) pleural effusion of unknown etiology after a microbiological (namely gram stain and acid fast bacillus stain) and cytological examination
- Significant hypoxemia on room air
- Hemodynamic instability
- Significant cardiac disease (known myocardial infarction in last 6 weeks or presence of unstable angina)
- Refractory cough
- Lack of pleural space due to adhesions
- Uncorrected coagulopathy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Rigid thoracoscopy Rigid thoracoscope (Richard Wolf GmbH, Knittlingen, Germany) Rigid thoracoscopy would be done using a rigid thoracoscope manufactured by Richard Wolf GmbH, Knittlingen, Germany. Semirigid thoracoscopy Semirigid thoracoscope (model LTF-160Y1, Olympus, Japan) The semirigid thoracoscope employed is a model LTF-160Y1, manufactured by Olympus Medical Systems Corporation, Tokyo, Japan.
- Primary Outcome Measures
Name Time Method Diagnostic yield of thoracoscopic biopsy by intention to treat analysis 3 months The proportion of patients where thoracoscopic pleural biopsy yielded a diagnosis that was consistent with the present clinical picture and the further follow-up of the patients, would be calculated and compared between the two arms
- Secondary Outcome Measures
Name Time Method Yield of biopsies successfully completed 3 months The diagnostic yield of only those procedures would be considered separately where a biopsy could be successfully done and compared between the two arms
Complications 3 months Number of major and minor complications encountered in the two arms
Scar size At the end of the procedure Scar size (in mm) in the longest axis
Biopsy size At the end of the procedure Biopsy size (in mm) in the longest axis
Trial Locations
- Locations (1)
Postgraduate Institute of Medical Education and Research
🇮🇳Chandigarh, India